Palisade Bio, Inc. Common Stock (NASDAQ: PALI) last traded at $1.59, up 3.25% on the session. The quote above updates while this page is open; the figures below are drawn from Palisade Bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
Palisade Bio, Inc. Common Stock trades on NASDAQ under the ticker PALI. Its market capitalisation is $277.09 million.
Valuation measures for Palisade Bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $277.09M |
|---|---|
| Enterprise value | $157.49M |
| Price / sales | 554.18 |
| Price / book | 2.28 |
| Beta | 1.27 |
Trailing-twelve-month figures tagged in Palisade Bio, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $500.0K |
|---|---|
| Net income (TTM) | -$31.94M |
| Operating margin | -7069.80% |
| Return on equity | -26.24% |
| Cash | $125.17M |
Range and volume for PALI over the past 52 weeks.
| 52-week high | $2.86 |
|---|---|
| 52-week low | $1.32 |
| Volume | 1.57M |
| Average volume | 2.52M |
| Previous close | $1.54 |
Invest a chosen dollar amount in Palisade Bio, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PALI.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.